The treatment of postpartum depression: minimizing infant exposures

The Journal of Clinical Psychiatry, 63 Suppl 7, 31-44

Source

Abstract

The first 3 postpartum months represent a high-risk period for psychiatric illnesses. This article reviews the prevalence and diagnostic criteria for postpartum illnesses, including the "maternal blues," postpartum depression, and postpartum psychosis. Pharmacologic treatment of these disorders is often complicated by a patient's desire to breast-feed, yet there are no controlled trials of antidepressant treatment during lactation. Infant exposure and limitations to monitoring infant sera are reviewed. Lastly, a model and guide for reducing fetal and infant exposures is presented.

Topics

postpartum depression pharmacologic treatment breastfeeding, antidepressant lactation infant exposure, postpartum psychosis maternal blues treatment review, postpartum depression medication breast milk infant safety, Newport Stowe postpartum depression treatment, reducing fetal infant antidepressant exposure breastfeeding, postpartum psychiatric illness prevalence diagnostic criteria, lactation antidepressant prescribing minimizing infant risk, postpartum depression pharmacotherapy guidelines nursing mothers

Cite this article

Newport, D. J., Hostetter, A., Arnold, A., & Stowe, Z. N. (2002). The treatment of postpartum depression: minimizing infant exposures. *The Journal of clinical psychiatry*, *63 Suppl 7*, 31-44.

Related articles